Quick Answer
Innoviva, Inc. reported Total Revenue of $411.33 million for fiscal year 2025.
Innoviva, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $411.33M +14.7% |
$358.71M +15.5% |
$310.46M -6.3% |
$331.34M -15.4% |
$391.87M +16.4% |
$336.79M +29.0% |
| Revenue (ASC 606) | $411.33M +14.7% |
$358.71M +15.5% |
$310.46M -6.3% |
$331.34M -15.4% |
$391.87M +16.4% |
$336.79M +29.0% |
| Diluted EPS | $3.30 +816.7% |
$0.36 -83.6% |
$2.20 -7.2% |
$2.37 -17.4% |
$2.87 +42.1% |
$2.02 +41.3% |
| Total Assets | $1.64B +25.7% |
$1.30B +4.6% |
$1.24B +1.0% |
$1.23B +32.9% |
$926.39M -7.3% |
$999.57M +37.9% |
| Cash and Equivalents | $550.94M +80.7% |
$304.96M +57.6% |
$193.51M -33.5% |
$291.05M +44.4% |
$201.53M -18.2% |
$246.49M -11.4% |
| Long-Term Debt | $257.73M +0.6% |
$256.32M -42.6% |
$446.23M +0.5% |
$444.18M +12.5% |
$394.65M +2.4% |
$385.52M +2.2% |
| Stockholders Equity | $1.17B +69.7% |
$691.16M +2.4% |
$674.96M +19.3% |
$565.79M +36.4% |
$414.74M -23.2% |
$539.91M +72.2% |
| R&D Expense | $30.60M +124.1% |
$13.65M -59.7% |
$33.92M -18.1% |
$41.43M +7093.1% |
$576.0K -67.8% |
$1.79M |
| Operating Income | $163.75M -1.9% |
$166.87M +46.5% |
$113.89M | — | $375.10M +16.8% |
$321.12M +30.3% |
| Gross Profit | $307.67M +3.9% |
$296.21M +20.4% |
$246.04M | — | — | — |
| Shares Outstanding | 74.64M +19.1% |
62.66M -1.0% |
63.31M -8.5% |
69.19M -0.5% |
69.57M -31.4% |
101.39M +0.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $107.80M | +20.4% | +7.5% |
| Revenue (ASC 606) | September 30, 2025 | $107.80M | +20.4% | +7.5% |
| Net Income | March 31, 2016 | $4.43M | +141.6% | +141.6% |
| Diluted EPS | September 30, 2025 | $1.08 | +5300.0% | +40.3% |
| Total Assets | September 30, 2025 | $1.43B | +16.0% | +7.2% |
| Cash and Equivalents | September 30, 2025 | $476.51M | +82.8% | +19.9% |
| Long-Term Debt | September 30, 2025 | $257.38M | +0.5% | +0.1% |
| Stockholders Equity | September 30, 2025 | $1.01B | +51.1% | +41.3% |
| R&D Expense | September 30, 2025 | $13.67M | +285.0% | +71.2% |
| Operating Income | September 30, 2025 | $34.58M | -20.0% | -29.1% |
| Gross Profit | September 30, 2025 | $75.54M | +3.5% | -9.1% |
| Shares Outstanding | September 30, 2025 | 74.77M | +19.4% | +18.7% |
- Innoviva, Inc. reported Total Revenue of $411.33 million for fiscal year 2025.
- Innoviva, Inc. showed an increase of +14.7% in Total Revenue compared to the prior fiscal year.
- Innoviva, Inc. reported Revenue (ASC 606) of $411.33 million for fiscal year 2025.
- Innoviva, Inc. showed an increase of +14.7% in Revenue (ASC 606) compared to the prior fiscal year.
- Innoviva, Inc. reported Diluted EPS of $3.30 per share for fiscal year 2025.
- Innoviva, Inc. showed an increase of +816.7% in Diluted EPS compared to the prior fiscal year.
- Innoviva, Inc. reported Total Assets of $1.64 billion for fiscal year 2025.
- Innoviva, Inc. showed an increase of +25.7% in Total Assets compared to the prior fiscal year.
- Innoviva, Inc. reported Cash and Equivalents of $550.94 million for fiscal year 2025.
- Innoviva, Inc. showed an increase of +80.7% in Cash and Equivalents compared to the prior fiscal year.
- Innoviva, Inc. reported Long-Term Debt of $257.73 million for fiscal year 2025.
- Innoviva, Inc. showed an increase of +0.6% in Long-Term Debt compared to the prior fiscal year.
- Innoviva, Inc. reported Stockholders Equity of $1.17 billion for fiscal year 2025.
- Innoviva, Inc. showed an increase of +69.7% in Stockholders Equity compared to the prior fiscal year.
- Innoviva, Inc. reported R&D Expense of $30.60 million for fiscal year 2025.
- Innoviva, Inc. showed an increase of +124.1% in R&D Expense compared to the prior fiscal year.
- Innoviva, Inc. reported Operating Income of $163.75 million for fiscal year 2025.
- Innoviva, Inc. showed a decrease of -1.9% in Operating Income compared to the prior fiscal year.
- Innoviva, Inc. reported Gross Profit of $307.67 million for fiscal year 2025.
- Innoviva, Inc. showed an increase of +3.9% in Gross Profit compared to the prior fiscal year.
- Innoviva, Inc. reported Shares Outstanding of 74.64 million shares for fiscal year 2025.
- Innoviva, Inc. showed an increase of +19.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: